New research in mice provides convincing evidence that digoxin, a drug prescribed to treat atrial fibrillation, can help protect against atherosclerosis.
Investigators found that digoxin decreased the levels of total cholesterol, triglycerides and LDL-cholesterol by 41%, 54%, and 20%, respectively, in mice treated with high-dose digoxin compared with control mice.
The findings are published in the British Journal of Pharmacology.
SARS-CoV-2 hijacks cholesterol trafficking to fuel infection and evade immune responses